Alyssa Vivas Ashley Barlond ENVH 472 Herbal remedy derived from plant (Ephedra sinica) Chinese herb derivative in dietary supplements Acts as a.
NUTR 547- Nutrition Update Kim McCorquodale Summer 2006 An Overview of Ephedra.
POSTMARKETING ADVERSE DRUG EXPERIENCE INSPECTIONAL PROGRAM CDR Thomas R. Berry, RPh FDA, Investigator RAL-RP / ATL-DO.
Ken Falci, Ph.D.,Director, OSAS Center for Food Safety and Applied Nutrition (CFSAN) FDA, College Park, MD.
Challenges in Classifying Adverse Events in Cancer Clinical Trials Steven Joffe, MD, MPH Dave Harrington, PhD David Studdert, JD, PhD Saul Weingart, MD,
1 One Year Post Exclusivity Adverse Event Review: Topotecan Pediatric Subcommittee of the Anti-infective Drugs Advisory Committee Meeting June 9, 2004.
Personal Care Products Safety Act - S.1014
Abnormal Psychology and Therapy By Jake Russell, Jesus Davis, and Thomas Shaw.
Ken Falci, Ph.D.,Director, OSAS Center for Food Safety and Applied Nutrition (CFSAN)
PDUFA & FDA Legislation
Ephedra Risk Assessment
2012 Annual Meeting “Towards Public Health Sector Transformation and Section Unity”